{
    "2021-09-21": [
        [
            {
                "time": "",
                "original_text": "Wellington Management Group LLP增持药明康德股份约18.56万股",
                "features": {
                    "keywords": [
                        "Wellington Management Group LLP",
                        "增持",
                        "药明康德",
                        "股份"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医药反弹是否可持续",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "反弹",
                        "可持续"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}